The hpv testing and pap test market is projected to grow from USD 4.5 billion in 2025 to USD 26.3 billion by 2035, at a CAGR of 19.3%. HPV Testing will dominate with a 54.6% market share, while vaginal cancer screening will lead the application segment with a 42.3% share.